PCG
GSK icon

Prosperity Consulting Group’s GSK GSK Stock Holding History

Prosperity Consulting Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Buy
22,735
+241
+1% +$13.1K 0.06% 211
2025
Q4 		$1.1M Sell
22,494
-892
-4% -$41.6K 0.05% 240
2025
Q3 		$1.01M Buy
23,386
+478
+2% +$18.7K 0.05% 247
2025
Q2 		$880K Sell
22,908
-574
-2% -$21.9K 0.06% 247
2025
Q1 		$910K Sell
23,482
-1,188
-5% -$43.5K 0.07% 235
2024
Q4 		$834K Buy
24,670
+724
+3% +$26.1K 0.06% 252
2024
Q3 		$979K Buy
+23,946
New +$980K 0.08% 231

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Prosperity Consulting Group's GSK Position: Q1 2026 in Review

Prosperity Consulting Group increased its GSK (GSK) stake by 1.1% in Q1 2026, buying an estimated $13.1K and bringing the position to 22,735 shares worth $1.25M. The position accounts for 0.06% of the portfolio, ranked #211.

Prosperity Consulting Group first reported a position in GSK in Q3 2024 and has held it in 7 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Prosperity Consulting Group held 22,735 shares of GSK worth $1.25M as of Q1 2026.
  • Prosperity Consulting Group bought 241 GSK shares in Q1 2026, an estimated $13.1K.
  • GSK made up 0.06% of Prosperity Consulting Group's portfolio in Q1 2026, its #211 holding.
  • Prosperity Consulting Group first reported a position in GSK in Q3 2024 and has held it in 7 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Prosperity Consulting Group's 13F filing for Q1 2026, filed 5 May 2026.